(Q36576015)

15 August 2017

1 reference

title

Saw palmetto and lower urinary tract symptoms: what is the latest evidence? (English)

1 reference

15 August 2017

Andrew L Avins

1

1 reference

15 August 2017

Stephen Bent

series ordinal

2

1 reference

15 August 2017

publication date

1 July 2006

1 reference

15 August 2017

published in

Current urology reports

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

260-265

1 reference

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial

15 August 2017

cites work

1 reference

12 December 2020

Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia

1 reference

12 December 2020

Phytotherapy in the treatment of benign prostatic hyperplasia: an update

1 reference

12 December 2020

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

1 reference

12 December 2020

Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease

1 reference

12 December 2020

Herbal Rx for prostate problems

1 reference

12 December 2020

Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

1 reference

12 December 2020

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action

1 reference

12 December 2020

Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.

1 reference

12 December 2020

In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.

1 reference

12 December 2020

Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts

1 reference

12 December 2020

A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens

1 reference

12 December 2020

Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

1 reference

12 December 2020

Phytotherapeutic agents in the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils

1 reference

12 December 2020

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon

1 reference

12 December 2020

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

The selectivity and specificity of the actions of the lipido-sterolic extract of Serenoa repens (Permixon) on the prostate

1 reference

12 December 2020

Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia

1 reference

12 December 2020

Serenoa repens for benign prostatic hyperplasia

1 reference

12 December 2020

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

12 December 2020

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

1 reference

12 December 2020

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon�) in benign prostatic hyperplasia

1 reference

12 December 2020

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

12 December 2020

Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells

1 reference

12 December 2020

Commonly used herbal medicines in the United States: a review

1 reference

12 December 2020

Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers

1 reference

12 December 2020

Herbal medicines and perioperative care

1 reference

12 December 2020

Effect of permixon on human prostate cell growth: lack of apoptotic action

1 reference

12 December 2020

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

12 December 2020

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

12 December 2020

Phytotherapy for benign prostatic hyperplasia

1 reference

12 December 2020

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

12 December 2020

Variations in Product Choices of Frequently Purchased Herbs

1 reference

12 December 2020

Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature

1 reference

12 December 2020

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

12 December 2020

10.1007/S11934-996-0004-2

Identifiers

DOI

1 reference

15 August 2017

1 reference